Advisory Committees

2013 Meeting Materials, Transmissible Spongiform Encephalopthies Advisory Commitee

Advisory Committee Meeting Materials:

March 14, 2013

On March 14, 2013, the Committee will meet in open session to discuss FDA’s draft risk assessment model for potential exposure to the variant Creutzfeldt-Jakob disease (vCJD) agent in Red Blood Cells for transfusion in the United States.

Page Last Updated: 08/25/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.